This indicates more significant diagnostic efficacies of TIPRL, LC3 and CD133 than the efficacy of CD46, previously reported in liver carcinogenesis, for an HCC incidence (Fig. 6h). This evidence concerns the gene PROM1 and hepatocellular carcinoma.